Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debra L Miller

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Circulation|December 7, 2007
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trialStephen D Wiviott, Dietmar Trenk, Andrew L Frelinger, et al.
The New England Journal of Medicine|September 3, 2013
Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromesGilles Montalescot, Leonardo Bolognese, Dariusz Dudek, et al.
Nature Communications|June 5, 2023
Broad host susceptibility of North American amphibian species to Batrachochytrium salamandrivorans suggests high invasion potential and biodiversity riskMatthew J Gray, Edward Davis Carter, Jonah Piovia-Scott, et al.
Journal of Aquatic Animal Health|February 16, 2021
Emerging Pathogens and a Current-Use Pesticide: Potential Impacts on Eastern HellbendersJ Patrick W Cusaac, Edward Davis Carter, Douglas C Woodhams, et al.
Current Epidemiology Reports|July 26, 2024
A New Paradigm for Pandemic PreparednessNina H Fefferman, John S McAlister, Belinda S Akpa, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Circulation|December 7, 2007
Prasugrel compared with high loading- and maintenance-dose clopidogrel in patients with planned percutaneous coronary intervention: the Prasugrel in Comparison to Clopidogrel for Inhibition of Platelet Activation and Aggregation-Thrombolysis in Myocardial Infarction 44 trialStephen D Wiviott, Dietmar Trenk, Andrew L Frelinger, et al.
The New England Journal of Medicine|September 3, 2013
Pretreatment with prasugrel in non-ST-segment elevation acute coronary syndromesGilles Montalescot, Leonardo Bolognese, Dariusz Dudek, et al.
Nature Communications|June 5, 2023
Broad host susceptibility of North American amphibian species to Batrachochytrium salamandrivorans suggests high invasion potential and biodiversity riskMatthew J Gray, Edward Davis Carter, Jonah Piovia-Scott, et al.
Journal of Aquatic Animal Health|February 16, 2021
Emerging Pathogens and a Current-Use Pesticide: Potential Impacts on Eastern HellbendersJ Patrick W Cusaac, Edward Davis Carter, Douglas C Woodhams, et al.
Current Epidemiology Reports|July 26, 2024
A New Paradigm for Pandemic PreparednessNina H Fefferman, John S McAlister, Belinda S Akpa, et al.
Pageof 12